207 related articles for article (PubMed ID: 27366902)
1. Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands.
Zampieri D; Vio L; Fermeglia M; Pricl S; Wünsch B; Schepmann D; Romano M; Mamolo MG; Laurini E
Eur J Med Chem; 2016 Oct; 121():712-726. PubMed ID: 27366902
[TBL] [Abstract][Full Text] [Related]
2. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
[TBL] [Abstract][Full Text] [Related]
3. Medicinal Chemistry of σ
Weber F; Wünsch B
Handb Exp Pharmacol; 2017; 244():51-79. PubMed ID: 28620761
[TBL] [Abstract][Full Text] [Related]
4. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ
Kopp N; Civenni G; Marson D; Laurini E; Pricl S; Catapano CV; Humpf HU; Almansa C; Nieto FR; Schepmann D; Wünsch B
Eur J Med Chem; 2021 Jul; 219():113443. PubMed ID: 33901806
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands.
Donnier-Maréchal M; Carato P; Le Broc D; Furman C; Melnyk P
Eur J Med Chem; 2015 Mar; 92():575-82. PubMed ID: 25602932
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.
Fallica AN; Pittalà V; Modica MN; Salerno L; Romeo G; Marrazzo A; Helal MA; Intagliata S
J Med Chem; 2021 Jun; 64(12):7926-7962. PubMed ID: 34076441
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Selectivity Profile of Sigma Receptor Ligands by Molecular Docking and Pharmacophore Analyses.
Righetti G; Tonelli M; Fossa P; Cichero E
Med Chem; 2021; 17(10):1151-1165. PubMed ID: 33155928
[TBL] [Abstract][Full Text] [Related]
8. Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.
Linkens K; Schmidt HR; Sahn JJ; Kruse AC; Martin SF
Eur J Med Chem; 2018 May; 151():557-567. PubMed ID: 29656199
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective σ1 receptor ligands.
Díaz JL; Christmann U; Fernández A; Luengo M; Bordas M; Enrech R; Carro M; Pascual R; Burgueño J; Merlos M; Benet-Buchholz J; Cerón-Bertran J; Ramírez J; Reinoso RF; Fernández de Henestrosa AR; Vela JM; Almansa C
J Med Chem; 2013 May; 56(9):3656-65. PubMed ID: 23560650
[TBL] [Abstract][Full Text] [Related]
10. Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands.
Laurini E; Marson D; Dal Col V; Fermeglia M; Mamolo MG; Zampieri D; Vio L; Pricl S
Mol Pharm; 2012 Nov; 9(11):3107-26. PubMed ID: 23020867
[TBL] [Abstract][Full Text] [Related]
11. Development of New Benzylpiperazine Derivatives as σ
Romeo G; Bonanno F; Wilson LL; Arena E; Modica MN; Pittalà V; Salerno L; Prezzavento O; McLaughlin JP; Intagliata S
ACS Chem Neurosci; 2021 Jun; 12(11):2003-2012. PubMed ID: 34019387
[TBL] [Abstract][Full Text] [Related]
12. Heterocyclic amino alcohols related to ifenprodil as sigma receptor ligands: binding and conformational analyses.
Beart PM; Ryan MC; Mercer LD; Jarrott B; Wong MG
Eur J Pharmacol; 1994 Oct; 269(2):193-200. PubMed ID: 7851495
[TBL] [Abstract][Full Text] [Related]
13. Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.
Meyer C; Schepmann D; Yanagisawa S; Yamaguchi J; Dal Col V; Laurini E; Itami K; Pricl S; Wünsch B
J Med Chem; 2012 Sep; 55(18):8047-65. PubMed ID: 22913577
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.
Yano H; Bonifazi A; Xu M; Guthrie DA; Schneck SN; Abramyan AM; Fant AD; Hong WC; Newman AH; Shi L
Neuropharmacology; 2018 May; 133():264-275. PubMed ID: 29407216
[TBL] [Abstract][Full Text] [Related]
15. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H
Szczepańska K; Podlewska S; Dichiara M; Gentile D; Patamia V; Rosier N; Mönnich D; Ruiz Cantero MC; Karcz T; Łażewska D; Siwek A; Pockes S; Cobos EJ; Marrazzo A; Stark H; Rescifina A; Bojarski AJ; Amata E; Kieć-Kononowicz K
ACS Chem Neurosci; 2022 Jan; 13(1):1-15. PubMed ID: 34908391
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
[TBL] [Abstract][Full Text] [Related]
17. Improving selectivity preserving affinity: new piperidine-4-carboxamide derivatives as effective sigma-1-ligands.
Zampieri D; Laurini E; Vio L; Fermeglia M; Pricl S; Wünsch B; Schepmann D; Mamolo MG
Eur J Med Chem; 2015 Jan; 90():797-808. PubMed ID: 25528334
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
Yarim M; Koksal M; Schepmann D; Wünsch B
Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety.
Bergkemper M; Kronenberg E; Thum S; Börgel F; Daniliuc C; Schepmann D; Nieto FR; Brust P; Reinoso RF; Alvarez I; Wünsch B
J Med Chem; 2018 Nov; 61(21):9666-9690. PubMed ID: 30350997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
